Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Anne Tschachera University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland

Cordula Cadusa University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland

Sebastian Schildgeb Boehringer Ingelheim GmbH, Basel, Switzerland

Jens Peter Diedrichb Boehringer Ingelheim GmbH, Basel, Switzerland

Prashant N. Chhajeda University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland;c Faculty of Medicine, University of Basel, Basel, Switzerland

Anne B. Leuppi-Taegtmeyera University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland;c Faculty of Medicine, University of Basel, Basel, Switzerland;d Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland

Jörg Daniel Leuppia University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland;c Faculty of Medicine, University of Basel, Basel, SwitzerlandCorrespondence[email protected]

show all

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date